Aug 4, 2022 7:00 am EDT American Gastroenterological Association (AGA) Clinical Practice Update States That TissueCypher® May Be Beneficial for Risk-Stratification of Patients with Non-Dysplastic Barrett’s Esophagus
Aug 3, 2022 7:00 am EDT Castle Biosciences to Present at the Canaccord Genuity 42nd Annual Growth Conference
Jul 25, 2022 5:00 pm EDT Castle Biosciences to Release Second Quarter 2022 Financial Results and Host Conference Call on Monday, August 8
Jul 25, 2022 7:00 am EDT DecisionDx®-Melanoma Ordered More Than 100,000 Times for Patients Diagnosed with Cutaneous Melanoma
Jul 20, 2022 7:00 am EDT Presentation at 2022 AAD Innovation Academy to Showcase the Risk Stratification of DecisionDx®-Melanoma and its Role in the Management of Patients with Cutaneous Melanoma
Jun 23, 2022 5:00 pm EDT Patients with Uveal Melanoma Tested with DecisionDx®-UM Report Gaining Value from Test Results In Study Conducted In Collaboration with the Melanoma Research Foundation’s CURE OM Initiative
Jun 22, 2022 7:00 am EDT Castle Adds to Evidence Supporting Its Skin Cancer Test Portfolio through Multiple Data Presentations at the SDPA Annual Summer Dermatology Conference 2022
